Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, today announced that Bill Newell , Chief Executive Officer, will participate in the Ovarian Cancer Panel discussion on March 2, 2021
February 23, 2021
· 3 min read